Deutsche Bank AG Sells 32,938 Shares of Chemed Co. (NYSE:CHE)

Deutsche Bank AG cut its stake in shares of Chemed Co. (NYSE:CHE - Free Report) by 93.7% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,203 shares of the company's stock after selling 32,938 shares during the period. Deutsche Bank AG's holdings in Chemed were worth $1,167,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of the business. Neuberger Berman Group LLC boosted its stake in shares of Chemed by 1.2% during the 4th quarter. Neuberger Berman Group LLC now owns 501,562 shares of the company's stock worth $265,726,000 after acquiring an additional 5,809 shares in the last quarter. Geode Capital Management LLC increased its holdings in Chemed by 1.5% during the 4th quarter. Geode Capital Management LLC now owns 340,409 shares of the company's stock valued at $180,654,000 after purchasing an additional 4,966 shares in the last quarter. FMR LLC boosted its position in Chemed by 18.9% in the 4th quarter. FMR LLC now owns 283,790 shares of the company's stock valued at $150,352,000 after buying an additional 45,174 shares during the last quarter. JPMorgan Chase & Co. boosted its position in Chemed by 8.2% in the 4th quarter. JPMorgan Chase & Co. now owns 266,786 shares of the company's stock valued at $141,343,000 after buying an additional 20,310 shares during the last quarter. Finally, Epoch Investment Partners Inc. boosted its position in shares of Chemed by 5.1% in the 4th quarter. Epoch Investment Partners Inc. now owns 252,237 shares of the company's stock worth $133,635,000 after purchasing an additional 12,167 shares during the last quarter. 95.85% of the stock is owned by institutional investors and hedge funds.

Chemed Stock Performance

Shares of CHE traded down $0.41 during trading hours on Friday, reaching $572.78. The stock had a trading volume of 3,680 shares, compared to its average volume of 102,824. The stock has a market capitalization of $8.38 billion, a PE ratio of 28.94, a PEG ratio of 2.15 and a beta of 0.59. Chemed Co. has a 12 month low of $512.12 and a 12 month high of $623.61. The company's 50-day moving average is $581.34 and its two-hundred day moving average is $565.81.

Chemed (NYSE:CHE - Get Free Report) last issued its quarterly earnings results on Wednesday, April 23rd. The company reported $5.63 earnings per share for the quarter, topping analysts' consensus estimates of $5.59 by $0.04. The firm had revenue of $646.94 million during the quarter, compared to the consensus estimate of $641.78 million. Chemed had a return on equity of 27.86% and a net margin of 12.69%. The business's revenue was up 9.8% compared to the same quarter last year. During the same period last year, the business posted $5.20 EPS. Equities analysts anticipate that Chemed Co. will post 21.43 earnings per share for the current fiscal year.

Chemed Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 17th. Stockholders of record on Thursday, May 29th will be paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 0.35%. The ex-dividend date of this dividend is Thursday, May 29th. Chemed's dividend payout ratio (DPR) is 9.74%.

Analyst Ratings Changes

CHE has been the topic of several recent analyst reports. Wall Street Zen upgraded Chemed from a "hold" rating to a "buy" rating in a report on Friday, March 7th. Royal Bank of Canada boosted their price target on Chemed from $667.00 to $674.00 and gave the stock an "outperform" rating in a research report on Monday, April 28th.

Insider Buying and Selling

In other Chemed news, CEO Kevin J. Mcnamara sold 1,000 shares of the stock in a transaction that occurred on Monday, March 31st. The shares were sold at an average price of $615.33, for a total value of $615,330.00. Following the transaction, the chief executive officer now directly owns 101,679 shares in the company, valued at approximately $62,566,139.07. This trade represents a 0.97% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Spencer S. Lee sold 1,500 shares of Chemed stock in a transaction on Friday, May 16th. The shares were sold at an average price of $577.99, for a total transaction of $866,985.00. Following the transaction, the executive vice president now owns 14,627 shares in the company, valued at approximately $8,454,259.73. This trade represents a 9.30% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 7,500 shares of company stock valued at $4,401,120 over the last three months. Corporate insiders own 3.29% of the company's stock.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.